NCS Multistage Holdings heads into its April 30 earnings call having already delivered the numbers — and they fell short.
Q1 results released after the close on April 29 showed revenue of $45.6M, missing the $51.2M consensus estimate. EPS came in at -$0.14, a miss of roughly $1.47 against expectations. The reaction lands at an awkward moment: the stock had already shed 11% on the week to $76, while its closest US-listed peers — AESI and PTEN — each climbed more than 11% over the same period.
The divergence from peers is the sharpest signal in the data. AESI gained 16.9% on the week. PTEN added 11.9%. NCS Multistage moved in the opposite direction while sentiment across oilfield services broadly improved. That gap raises the question of whether the revenue miss was already partially priced in by market participants, or whether the stock faces further de-rating once trading resumes.
The short positioning story is too thin to be the main driver here. Short interest is minimal — just 0.18% of the free float — even though it roughly tripled over April, rising 279% on the month. In absolute terms, fewer than 4,600 shares are estimated short. Borrow availability remains ample and cost to borrow has edged up to around 5% from under 3% a week ago, but neither reading suggests any meaningful squeeze dynamic. The short score of 27 sits well below any level that would flag short-side conviction.
What the ownership structure does flag is concentration risk. Advent International holds 57.8% of shares, leaving a very thin float. The top five holders account for more than 70% of the company. On the insider side, the CEO, CFO and COO all sold shares in early March at prices near $40 — roughly half today's close of $76. Those sales were relatively modest in dollar terms ($427K for the CEO), but the timing — ahead of a sharp run-up — will draw scrutiny on the call.
Prior earnings prints showed explosive post-announcement moves: the stock jumped roughly 22% on the day and 44% over five days following the March 2026 event, with similar magnitude reactions in adjacent quarters. The setup this time is less constructive: revenue missed, the stock already underperformed peers heading in, and the float is too narrow for institutional repositioning to happen quietly. The call will test whether management can explain the gap to estimates and credibly defend whether the recent price appreciation — up 86% since early March — reflects demand conditions or something more episodic.
See the live data behind this article on ORTEX.
Open NCSM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
